Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Strides Pharma Science Ltd ( (IN:STAR) ) just unveiled an announcement.
Strides Pharma Science Ltd has published extracts of its unaudited financial results for the quarter and nine months ended 31 December 2025 in the Financial Express and Lokmat newspapers, in line with regulatory disclosure requirements. The company has also made these financial results available on its website, underscoring its compliance with securities listing norms and its ongoing commitment to transparent financial reporting for investors and other stakeholders.
More about Strides Pharma Science Ltd
Strides Pharma Science Ltd is an India-based pharmaceutical company engaged in the development, manufacture and marketing of generic pharmaceutical products. The company focuses on regulated and emerging markets, supplying a range of formulations across therapeutic segments through its global network and branded generics presence.
Average Trading Volume: 28,576
Technical Sentiment Signal: Strong Buy
Current Market Cap: 80.9B INR
For an in-depth examination of STAR stock, go to TipRanks’ Overview page.